German doctors vote to cut healthcare spending
This article was originally published in Clinica
German doctors have agreed to restrict non-essential medical procedures in an attempt to reduce healthcare spending, according to Handelsblatt. At the annual meeting of the Federal Kassen Doctors Association (KBV) last week, delegates finally accepted the need for cost reduction, particularly in the hospital sector, and charged the KBV executive to work with other doctors' unions to achieve a consensus on reimbursement reform.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.